Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Yujin Artificial Intelligence Medical Technology is a Chinese medtech company specializing in artificial intelligence solutions for healthcare. Its core products include real-time computer-aided detection systems used during gastrointestinal endoscopy to improve the identification of polyps and other lesions. The company's technology leverages deep learning models trained on large datasets to assist clinicians with accurate, efficient diagnoses. It has filed patents related to multi-modal data fusion methods for enhanced evaluation in clinical practice. Peer-reviewed studies have validated its system's performance in live hospital settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Yujin Artificial Intelligence Medical Technology.